BeStock  
Stocks › Biotechnology › RCUS

Arcus Biosciences RCUS

US equityMarket cap rank #2610Biotechnology
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.8x
CheapRich

Around its usual level · 46th percentile, 5-year average 1.6x

Price / book7.0x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average 3.3x

#4717 of 5330 stocks by PB (1 = cheapest)

Price / sales25.1x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average 12.6x

#4775 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-18x7x32x57xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$29.64
Price vs. fair value-47.3%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.01 – 3.29 95% (pricier than usual) #4717 of 5330 (1 = cheapest)
PE -4.79 -5.49 1.59 46% (cheaper than usual) –
PS 25.10 114.26 12.58 90% (pricier than usual) #4775 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RCUS.

Sign in to join the discussion.

Scroll to Top